TIMP1 (tissue inhibitor of matrix metalloproteinase 1) was shown to be correlated with cancer progression, specifically in GBM, and is significantly overexpressed in tumor-infiltrating lymphocytes [47]. Here, TIMP1 is linked to glioblastoma.